[go: up one dir, main page]

EP1130015A4 - Derives de pyridazinone - Google Patents

Derives de pyridazinone

Info

Publication number
EP1130015A4
EP1130015A4 EP99937056A EP99937056A EP1130015A4 EP 1130015 A4 EP1130015 A4 EP 1130015A4 EP 99937056 A EP99937056 A EP 99937056A EP 99937056 A EP99937056 A EP 99937056A EP 1130015 A4 EP1130015 A4 EP 1130015A4
Authority
EP
European Patent Office
Prior art keywords
optionally substituted
heterocyclic group
aromatic heterocyclic
phenyl
pyridazinone derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99937056A
Other languages
German (de)
English (en)
Other versions
EP1130015A1 (fr
Inventor
Makoto Gotoh
Koji Umimoto
Masanobu Onishi
Akiyuki Satoh
Yoshitami Oshita
Masashi Nagamine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nihon Nohyaku Co Ltd
Original Assignee
Nihon Nohyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Nohyaku Co Ltd filed Critical Nihon Nohyaku Co Ltd
Publication of EP1130015A1 publication Critical patent/EP1130015A1/fr
Publication of EP1130015A4 publication Critical patent/EP1130015A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/18—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/28—Cinnolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

L'invention concerne des dérivés de pyridazinone représentés par la formule générale (1), y compris leurs sels médicalement acceptables, ainsi que des compositions médicamenteuses dans lesquelles les produits en question tiennent lieu de principe actif. Dans ladite formule, R1 est phényle éventuellement substitué ou un groupe aromatique hétérocyclique; R2 est aralkyle, phényle ou alkyle éventuellement substitué, un groupe aromatique hétérocyclique, amino, amino cyclique, cyano, carboxyle ou autre; R3 est hydrogène, phényle ou alkyle éventuellement substitué ou un groupe aromatique hétérocyclique; et R4 est cyano, carbonyle ou autre.
EP99937056A 1998-08-14 1999-08-12 Derives de pyridazinone Withdrawn EP1130015A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP22962398 1998-08-14
JP22962398 1998-08-14
PCT/JP1999/004384 WO2000009488A1 (fr) 1998-08-14 1999-08-12 Derives de pyridazinone

Publications (2)

Publication Number Publication Date
EP1130015A1 EP1130015A1 (fr) 2001-09-05
EP1130015A4 true EP1130015A4 (fr) 2006-02-08

Family

ID=16895102

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99937056A Withdrawn EP1130015A4 (fr) 1998-08-14 1999-08-12 Derives de pyridazinone

Country Status (7)

Country Link
US (1) US6469003B1 (fr)
EP (1) EP1130015A4 (fr)
KR (1) KR100657189B1 (fr)
CN (1) CN1263746C (fr)
AU (1) AU756275B2 (fr)
CA (1) CA2340230C (fr)
WO (1) WO2000009488A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2279428C2 (ru) * 2000-09-18 2006-07-10 Эйсай Ко., Лтд. Производные пиридазинона и триазинона и их применение в качестве фармацевтических препаратов
HU228961B1 (en) * 2000-09-18 2013-07-29 Eisai R & D Man Co Triazinones and their use as active ingredients of pharmaceutical compositions
JP2007522225A (ja) * 2004-02-10 2007-08-09 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ Ａ４インテグリン拮抗薬としてのピリダジノン
CA2555227A1 (fr) * 2004-02-10 2005-08-25 Janssen Pharmaceutica, N.V. Urees de pyridazinone utilisees en tant qu'antagonistes des integrines .alpha.4
DE102004056226A1 (de) * 2004-11-22 2006-05-24 Burchardt, Elmar Reinhold, Dr.Dr. Neuartige Inhibitoren der Lysyloxidase
EP2099770B1 (fr) 2006-12-21 2015-06-10 Sloan-Kettering Institute for Cancer Research Pyridazinones et composés furanniques
DE102008019907A1 (de) * 2008-04-21 2009-10-22 Merck Patent Gmbh Pyridazinonderivate
SI2393360T1 (sl) 2009-02-05 2016-02-29 Takeda Pharmaceutical Company Limited Piridazinonske spojine
ES2544869B2 (es) 2014-03-04 2016-01-18 Universidade De Vigo Derivados de piridazin-3(2H)-ona inhibidores selectivos de la isoforma B de la monoaminooxidasa
KR20190009369A (ko) * 2016-05-25 2019-01-28 바이엘 파마 악티엔게젤샤프트 3-옥소-2,6-디페닐-2,3-디히드로피리다진-4-카르복스아미드
JOP20190193A1 (ar) 2017-02-09 2019-08-08 Bayer Pharma AG ممركبات 2-أريل غير متجانس-3-أكسو-2، 3-ثنائي هيدرو بيريدازين-4-كربوكساميد لمعالجة السرطان
PT3580211T (pt) * 2017-11-21 2021-02-01 Deutsches Krebsforsch 2-heteroaril-3-oxo-2,3-di-hidropiridazina-4-carboxamidas para o tratamento de cancro
CA3082857A1 (fr) * 2017-11-21 2019-05-31 Bayer Aktiengesellschaft 3-oxo-6-heteroaryl-2-phenyl-2,3-dihydropyridazine-4-carboxamides

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999010331A1 (fr) * 1997-08-22 1999-03-04 Abbott Laboratories Arylpyridazinones inhibitrices de la biosynthese de la prostaglandine endoperoxyde h synthase

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62223176A (ja) 1986-03-25 1987-10-01 Nissan Chem Ind Ltd ピリダジノン誘導体，その製法および殺虫，殺ダニ，殺線虫剤
ES2125474T3 (es) 1993-09-06 1999-03-01 Ishihara Sangyo Kaisha Derivados de piridazinona o sus sales, procedimentos para su produccion y agentes anti-shock que los contienen.
IL115889A0 (en) 1994-11-14 1996-01-31 Rohm & Haas Pyridazinones and their use as fungicides
US6013674A (en) 1997-06-02 2000-01-11 Eli Lilly And Company Cell adhesion inhibitors

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999010331A1 (fr) * 1997-08-22 1999-03-04 Abbott Laboratories Arylpyridazinones inhibitrices de la biosynthese de la prostaglandine endoperoxyde h synthase

Non-Patent Citations (13)

* Cited by examiner, † Cited by third party
Title
A.W. ERIAN ET AL, MONATSH. CHEM., vol. 130, no. 5, 1999, pages 661 - 669, XP008052753 *
A.W.K. DE JONG, RECL. TRAV. CHIM. PAYS-BAS, vol. 22, no. 4-5, 1903, pages 281 - 289, XP008056771 *
F. AL-OMRAN ET AL, SYNTHESIS, no. 1, 1997, pages 91 - 94, XP002344891 *
F.M. MANHI ET AL, COLLECT. CZECH. CHEM. COMMUN., vol. 57, no. 8, 1992, pages 1770 - 1774, XP008052826 *
H. AL-AWADHI ET AL, TETRAHEDRON, vol. 51, no. 46, 1995, pages 12745 - 12762, XP004104656 *
K. GEWALD ET AL, MONATSH. CHEM., vol. 126, no. 3, 1995, pages 341 - 347, XP008052761 *
M.E. HASSAN ET AL, ASWAN SCIENCE & TECHNOLOGY BULLETIN, no. 13, 1992, pages 33 - 44, XP008052754 *
M.H. ELNAGDI ET AL, TETRAHEDRON, vol. 45, no. 11, 1989, pages 3597 - 3604, XP002344890 *
M.H. ELNAGDI ET AL, Z. NATURFORSCH. B, vol. 44, no. 6, 1989, pages 683 - 689, XP008053233 *
R. FUSCO ET AL, GAZZ. CHIM. ITAL., vol. 102, 1972, pages 431 - 444, XP008052756 *
S. EL-KOUSY ET AL, COLLECT. CZECH. CHEM. COMMUN., vol. 55, no. 12, 1990, pages 2977 - 2986, XP008052762 *
S.A.S. GHOZLAN ET AL, GAZZ. CHIM. ITAL., vol. 119, no. 2, 1989, pages 95 - 97, XP009037004 *
See also references of WO0009488A1 *

Also Published As

Publication number Publication date
AU756275B2 (en) 2003-01-09
CA2340230A1 (fr) 2000-02-24
EP1130015A1 (fr) 2001-09-05
CN1263746C (zh) 2006-07-12
CA2340230C (fr) 2008-03-11
AU5197699A (en) 2000-03-06
US6469003B1 (en) 2002-10-22
KR20010072465A (ko) 2001-07-31
CN1323297A (zh) 2001-11-21
WO2000009488A1 (fr) 2000-02-24
KR100657189B1 (ko) 2006-12-14

Similar Documents

Publication Publication Date Title
EP1156045A4 (fr) Derives d'amides et compositions de medicaments
WO2003037862A1 (fr) Derives amide, et medicaments correspondants
EP1203768A4 (fr) Derives d'isoxazoline et herbicides contenant ces derniers sous forme de composants actifs
ATE223378T1 (de) Prolineamid-derivate
CA2318527A1 (fr) Inhibiteurs de l'adhesion cellulaire a mediation par .alpha.4
CA2311742A1 (fr) Nouveaux composes heterocycliques
DE60015523D1 (de) Kosmetische zusammensetzungen
EP1243268A4 (fr) Composition medicinale
DK0976748T3 (da) Pyrrolidinderivater med phospholispase A2-hæmmende aktivitet
EP1130015A4 (fr) Derives de pyridazinone
EP1642880A4 (fr) Inhibiteur de proteines de la famille hsp90
WO2000039083A3 (fr) Composes pyrazole et utilisation de tels composes
PT842923E (pt) Derivados do pirrolo e composicoes medicinais
IL136359A (en) Dihydrobenzofuran substituted phthalazin-1-one derivatives and pharmaceutical compositions containing the same
WO2002000638A8 (fr) Nouveaux phthalides substitues, leur procede de preparation et compositions pharmaceutiques les contenant
EP1813270A4 (fr) Inhibiteurs des proteines de la famille hsp90
NO972938L (no) Farmasöytiske piperazinforbindelser
NO955328L (no) Pyridazinon-derivater
KR920701240A (ko) 글루타티온 유도체
WO2003031414A1 (fr) Nouveau compose heterocyclique et agent anti-inflammatoire
DK0844241T3 (da) Inhibitor af narkotisk analgetisk afhængighed/resistensudvikling
WO2001079170A3 (fr) Derives d'aminophenoxyacetamide et composition pharmaceutique les contenant
EP0997463A4 (fr) Derives de naphthyridine
EP1219619A4 (fr) Derives de piperidine
EP1142875A4 (fr) Derives de cinnamamide et compositions medicamenteuses renfermant ces derives

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010214

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): CH DE FR GB IT LI

A4 Supplementary search report drawn up and despatched

Effective date: 20051223

17Q First examination report despatched

Effective date: 20080704

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110301